Weekly Events Preview — September 28 – October 02, 2026


Calendar At-a-Glance

Monday, September 28

Before Open: Adyen N.V. (ADYEY), Genius Group Limited (GNS), Addex Therapeutics (ADXN), AMEN Properties (AMEN), American Cannabis Company (AMMJ) After Close: Inventiva S.A. (IVA), Jefferies Financial Group (JEF), Vail Resorts (MTN) Events: None

Tuesday, September 29

Before Open: Carnival Corporation (CCL), CarMax (KMX), AGM Group Holdings (AGMH), Allurion Technologies (ALUR), BriaCell Therapeutics (BCTX) After Close: AAR Corp. (AIR), Concentrix Corporation (CNXC), Gold Resource Corporation (GORO) Events: None

Wednesday, September 30

Before Open: Conagra Brands (CAG), Jabil Inc. (JBL), Uranium Energy Corp. (UEC), FactSet Research Systems (FDS) After Close: Micron Technology (MU), Progress Software (PRGS), AtlasClear Holdings (ATCH), Bassett Furniture Industries (BSET) Events: None

Thursday, October 1

Before Open: Accenture plc (ACN), Acuity Inc. (AYI), McCormick & Company (MKC), NioCorp Developments (NB), iShares MSCI Poland ETF (EPOL) After Close: NIKE, Inc. (NKE), FreeCast (CAST), Tamboran Resources (TBN) Events: None

Friday, October 2

Before Open: NovaGold Resources (NG), Alliance National Municipal Income Fund (AFB), Amerityre Corp. (AMTY), BAB Inc. (BABB), Blue Buffalo Pet Products (BUFF), Corus Entertainment B (CJREF), HomesToLife (HTLM), Madison County Financial (MCBK) Events: None

⚠️ Note: The economic events provided (Unemployment Claims, Revised UoM Consumer Sentiment, Revised UoM Inflation Expectations) are dated September 24–25, which fall in the prior week. They are covered in the Economic Calendar section for context and carry-over market impact into this week’s trading.


Earnings to Watch


📅 Monday, September 28


ADYEY — Adyen N.V. | Reports: Monday, September 28 (Before Open) Consensus: EPS N/A | Revenue N/A Action: HOLD/WATCH — No consensus estimates available; treat as a news-driven event only. Claude’s take: Adyen is one of Europe’s premier fintech payment processors, competing with Stripe, Block, and PayPal in global merchant acquiring. The company famously cratered ~40% in a single session in August 2023 after missing revenue and margin targets badly, which reset investor expectations dramatically. Since then, the Street has been more conservative in modeling Adyen’s growth trajectory. With no published consensus for this ADR print, swing traders should wait for the first 30-minute candle post-open before committing — the bid/ask spreads on ADYEY can be brutal, and the ADR structure means liquidity is thin for retail. Watch for commentary on North American merchant expansion, which was the key catalyst for the recovery thesis.


GNS — Genius Group Limited | Reports: Monday, September 28 (Before Open) Consensus: EPS N/A (placeholder 999 in data) | Revenue N/A Action: AVOID — Micro-cap with no reliable consensus; speculative and illiquid. Claude’s take: Genius Group is a small-cap entrepreneur education and EdTech company that trades with extremely low float and high volatility. The “999” EPS placeholder in the data confirms there is no meaningful analyst coverage or consensus estimate, which is a red flag for swing traders. These prints can move 30–60% on zero fundamental news simply due to thin float and retail speculation. There is no edge here — I’d avoid this entirely unless you’re willing to treat it as a lottery ticket with position sizing of less than 0.5% of portfolio.


IVA — Inventiva S.A. | Reports: Monday, September 28 (After Close) Consensus: EPS -$0.20 | Revenue ~$0 Action: AVOID — Clinical-stage biotech with binary risk; no revenue and burning cash. Claude’s take: Inventiva is a French clinical-stage biotech focused on metabolic diseases, including NASH/MAFLD and lysosomal storage disorders. Their lead asset, lanifibranor, has had mixed Phase 3 data and the company generates essentially zero commercial revenue. With an EPS estimate of -$0.20 and no revenue base, this print is entirely about pipeline updates and cash runway commentary rather than financial performance. Swing traders have no edge on biotech binary events of this size — the options market will price in the uncertainty and the spread will be punishing. Skip it unless you’re a biotech specialist with deep knowledge of the NASH competitive landscape.


JEF — Jefferies Financial Group Inc. | Reports: Monday, September 28 (After Close) Consensus: EPS $1.04 | Revenue $2.08B Action: BUY — Lean long into the print; investment banking recovery cycle favors a beat. Claude’s take: Jefferies is one of the most reliable early read-throughs for Wall Street’s capital markets activity, reporting ahead of the big-bank earnings season in mid-October. The consensus of $1.04 EPS on $2.08B revenue reflects a meaningful ramp versus prior-year periods when deal volumes were suppressed by elevated rate uncertainty. With M&A and ECM pipelines rebuilding through 2025-2026 as the Fed’s rate-cutting cycle took hold, Jefferies should benefit from stronger advisory fees and underwriting revenue. If JEF beats and raises activity commentary, it’s a green light for the entire financial sector heading into JPM/GS/MS earnings — buy the sector ETF (XLF) on any post-JEF dip. The risk: if deal flow commentary disappoints, it telegraphs weakness across the entire investment banking complex.


MTN — Vail Resorts, Inc. | Reports: Monday, September 28 (After Close) Consensus: EPS -$5.31 | Revenue $0.27B Action: HOLD/WATCH — Seasonally weak quarter; the market knows this, but guidance is what matters. Claude’s take: Vail Resorts reports its fiscal Q4, which covers the spring/summer shoulder season — structurally the weakest quarter of the year for a ski resort operator, so that -$5.31 EPS estimate is not alarming in isolation. The real question is fiscal year guidance and early season pass sales data for the 2026-2027 ski season, which management will update on the call. MTN has been range-bound and underperformed as discretionary travel spending came under pressure from higher-for-longer rates in 2024-2025. If early pass sales data is strong (indicating healthy consumer intent), this could be a catalyst for a bounce. I’d watch the stock’s reaction in the first hour after the print — a hold above the 50-day moving average on bad numbers would be bullish. A break below on light pass sales would signal real distribution.


ADXN — Addex Therapeutics Ltd | Reports: Monday, September 28 (Before Open) Consensus: N/A | Revenue N/A Action: AVOID — Nano-cap clinical biotech with no estimates; binary and illiquid. Claude’s take: Addex is a Swiss clinical-stage neuroscience company focused on allosteric modulators. With no EPS estimate and no revenue, this is purely a pipeline-update event. There is no swing trade setup here for a rational risk manager.


AMEN — AMEN Properties Inc | Reports: Monday, September 28 (Before Open) Consensus: N/A | Revenue N/A Action: AVOID — No estimates, minimal liquidity, no actionable setup. Claude’s take: AMEN Properties is a tiny real estate holding company with minimal analyst coverage and negligible trading volume. There is no swing trade thesis here.


AMMJ — American Cannabis Company Inc. | Reports: Monday, September 28 (Before Open) Consensus: N/A | Revenue N/A Action: AVOID — Cannabis micro-cap; sector remains structurally challenged with no federal catalyst this week. Claude’s take: American Cannabis Company is a small-cap cannabis operator in a sector that continues to face margin compression, state-by-state regulatory fragmentation, and illicit market competition. Without any consensus estimates or a near-term federal rescheduling catalyst, there is no swing trade edge here.


📅 Tuesday, September 29


CCL — Carnival Corporation & plc | Reports: Tuesday, September 29 (Before Open) Consensus: EPS $1.36 | Revenue $8.37B Action: BUY — Strongest setup of the early week; consumer travel demand remains robust and the stock has room to run. Claude’s take: Carnival is the single most-anticipated name of the first half of this week (anticipation score: 14), and for good reason — it’s the best barometer for consumer leisure spending and international travel recovery. The consensus of $1.36 EPS on $8.37B revenue represents a high-water mark for the company’s post-COVID earnings trajectory, and recent commentary from peers like Royal Caribbean and Norwegian Cruise Line has been uniformly bullish on pricing power and advance booking trends. The risk here is that CCL has likely run into the print — check the 30-day chart closely. If the stock is up 15%+ in the past month, it may be “priced for perfection” and a beat-and-raise could trigger a sell-the-news response. The smarter play may be to buy any weakness on the day before earnings (Monday) if the stock pulls back to support, rather than chasing into the number. Watch for commentary on European itinerary pricing and China cruise demand, both incremental growth vectors.


KMX — CarMax, Inc. | Reports: Tuesday, September 29 (Before Open) Consensus: EPS $0.66 | Revenue $7.06B Action: HOLD/WATCH — Used vehicle market is stabilizing but not accelerating; the print is a coin flip. Claude’s take: CarMax is a critical macro data point — it tells you whether the used car market has fully digested the post-pandemic price normalization or whether further margin compression lies ahead. The $0.66 EPS estimate on $7.06B revenue reflects modest recovery expectations after a prolonged period of declining used vehicle prices eating into CarMax’s gross profit per unit (GPU). The key metric to watch is GPU, which bottomed in the $2,000-$2,100 range and has been trying to recover. If GPU comes in above $2,200 per unit and financing spreads hold (through CarMax Auto Finance), this is a clear beat catalyst. Conversely, if GPU disappoints, expect KMX and the broader consumer discretionary space (CVNA, AN, PAG) to sell off hard. This is a better pair-trade setup than a pure directional bet — if the macro data from the prior week (UoM Consumer Sentiment at 47.5, signaling stress) carries into this print, KMX could miss.


AIR — AAR Corp. | Reports: Tuesday, September 29 (After Close) Consensus: N/A (placeholder) | Revenue N/A Action: WATCH — Aviation MRO (Maintenance, Repair & Overhaul) names are in a structural upcycle; worth monitoring for sector read-through. Claude’s take: AAR Corp is an aviation services company providing MRO services and parts supply to commercial and government aviation customers. The “999” EPS placeholder suggests no formal consensus, likely because AAR is a smaller-cap name with limited Street coverage. However, the aviation MRO sector is genuinely one of the strongest structural growth stories in industrials right now — aging global commercial fleets, supply chain constraints on new aircraft deliveries, and booming travel demand are all driving demand for third-party maintenance. A strong AAR print would be positive read-through for Heico (HEI), TransDigm (TDG), and other aerospace aftermarket names. No options strategy here given no consensus, but watch the print for sector intelligence.


CNXC — Concentrix Corporation | Reports: Tuesday, September 29 (After Close) Consensus: EPS $2.40 | Revenue $2.48B Action: SHORT/AVOID — BPO sector faces structural AI disruption; low expectations but the thesis is broken. Claude’s take: Concentrix is a business process outsourcing (BPO) company that operates large-scale customer experience and back-office operations for enterprise clients. The elephant in the room is generative AI — every major enterprise buyer is asking how much of their CX outsourcing spend can be automated away by AI agents, and Concentrix is directly in the crosshairs. The company carries meaningful debt from its Webhelp acquisition and has seen margin pressure as pricing power weakens in contract renewals. While $2.40 EPS on $2.48B revenue looks like a low bar, I’d be cautious about calling this an “easy beat setup” — the concern is forward guidance and contract renewal commentary, not just the current quarter. If management signals AI-driven customer attrition or margin headwinds, this stock could gap down despite meeting consensus. The risk/reward skews to the downside.


GORO — Gold Resource Corporation | Reports: Tuesday, September 29 (After Close) Consensus: N/A (placeholder) | Revenue N/A Action: AVOID — Small-cap gold/silver miner; no consensus, thin liquidity. Claude’s take: Gold Resource Corporation is a small precious metals mining company operating in Mexico and Nevada. With no published consensus estimates and thin trading volume, this is not an actionable swing trade setup. Gold prices have been strong in 2025-2026, which is a tailwind, but individual miner execution risk at the small-cap level is too idiosyncratic for a clean swing trade.


AGMH — AGM Group Holdings Inc. | Reports: Tuesday, September 29 (Before Open) Consensus: N/A | Revenue N/A Action: AVOID — Crypto/fintech micro-cap; no estimates, extreme volatility risk. Claude’s take: AGM Group is a small crypto and fintech services company. No estimates, no liquidity, no edge for a swing trader.


ALUR — Allurion Technologies, Inc. | Reports: Tuesday, September 29 (Before Open) Consensus: N/A | Revenue N/A Action: AVOID — Medical device company in weight loss space; no estimates and high binary risk. Claude’s take: Allurion makes a swallowable gastric balloon for weight loss. While the GLP-1 obesity treatment space has reset the competitive landscape for all weight loss devices, individual micro-cap names in this space carry disproportionate risk from regulatory and competitive dynamics. No consensus estimates means no actionable setup.


BCTX — BriaCell Therapeutics | Reports: Tuesday, September 29 (Before Open) Consensus: N/A | Revenue N/A Action: AVOID — Clinical-stage oncology biotech; no estimates, binary pipeline risk. Claude’s take: BriaCell is a clinical-stage immunotherapy company focused on breast cancer. No revenue, no estimates, no swing trade setup for a rational risk manager.


📅 Wednesday, September 30


MU — Micron Technology, Inc. | Reports: Wednesday, September 30 (After Close) Consensus: EPS $31.24 | Revenue $50.76B Action: BUY (but manage size) — The single most important earnings report of the week; a beat-and-raise could ignite the entire semiconductor sector. Claude’s take: Micron is the crown jewel of this week’s earnings calendar with an anticipation score of 127 — nearly 5x the next highest name (NKE at 24). This is the most watched semiconductor print of Q4 2026, and for good reason: Micron is the primary publicly-traded barometer for DRAM and NAND memory demand, which is directly tied to AI infrastructure buildout, data center capex, and the smartphone/PC upgrade cycle. The consensus of $31.24 EPS on $50.76B revenue represents a staggering recovery from the memory downcycle of 2022-2023 — if accurate, this reflects near-peak profitability. The AI angle is critical: HBM (High Bandwidth Memory) demand from Nvidia’s GB200 NVL racks and AMD’s MI400-series GPUs is reportedly capacity-constrained, and Micron is one of only three global HBM suppliers. A beat on HBM revenue and raised HBM guidance for FY2027 would be massively bullish for MU and the entire semiconductor complex (NVDA, AMD, AMAT, LRCX, ASML). The risk: if MU’s guidance for Q1 2027 disappoints or if they flag any softness in consumer NAND demand, the stock could give back gains even on a headline beat. Position sizing matters here — buy call spreads rather than naked calls given the elevated implied volatility heading into the print. The post-earnings sector move will define the tape for the rest of October.


CAG — Conagra Brands, Inc. | Reports: Wednesday, September 30 (Before Open) Consensus: EPS $0.31 | Revenue $2.59B Action: HOLD/AVOID — Packaged food sector faces private-label competition and GLP-1 demand headwinds; limited upside. Claude’s take: Conagra is a large packaged food company (Slim Jim, Birds Eye, Healthy Choice, Hunt’s). The $0.31 EPS on $2.59B revenue is a modest bar, but the sector faces compounding headwinds: private-label market share gains as consumers trade down, volume declines as GLP-1 drug users reduce snack consumption (a genuinely structural volume headwind for the category), and commodity cost tailwinds that are increasingly priced in. Recent quarters across CPG names (GIS, HRL, K) have shown that beating earnings doesn’t necessarily lift the stocks — the multiple has compressed and the growth re-rating isn’t happening yet. I’d avoid building a position ahead of this print. If CAG misses on volume (organic growth), the stock could underperform significantly. The only bullish scenario: a meaningful cost-cutting or portfolio-rationalization announcement on the call.


JBL — Jabil Inc. | Reports: Wednesday, September 30 (Before Open) Consensus: EPS $3.86 | Revenue $9.61B Action: BUY — Electronics manufacturing services with AI hardware exposure; this is an underappreciated AI infrastructure play. Claude’s take: Jabil is one of the world’s largest electronics manufacturing services (EMS) companies, producing components and assemblies for Apple, healthcare OEMs, industrial automation, and increasingly, AI data center infrastructure. The $3.86 EPS on $9.61B revenue consensus reflects solid but not euphoric expectations — Jabil has been quietly rebuilding its margins after divesting its mobility segment (which included Apple iPhone assembly). The remaining business is higher-margin and more diversified. The key catalyst to watch: any incremental AI/data center infrastructure revenue disclosure. If Jabil confirms growing exposure to hyperscaler server assemblies or power management hardware for AI racks, the stock deserves a re-rating. This is a potentially overlooked setup where the stock may not have “run up” to the same degree as pure-play AI names, offering better risk/reward. A beat here would be bullish for the EMS sector broadly (Flex, Celestica).


UEC — Uranium Energy Corp. | Reports: Wednesday, September 30 (Before Open) Consensus: EPS -$0.04 | Revenue $0.01B Action: HOLD/WATCH — Uranium bull cycle is real, but UEC is still ramping production; the print matters less than uranium spot price. Claude’s take: Uranium Energy is a US-based uranium miner that has been ramping production at its South Texas and Wyoming ISR (In-Situ Recovery) operations. The -$0.04 EPS on essentially zero revenue reflects the company’s early-stage production ramp — this is still largely a uranium price/NAV story rather than an earnings story. The relevant context: uranium spot prices have been elevated above $80/lb, driven by AI-related nuclear power demand (data centers signing power purchase agreements with nuclear plants), SMR enthusiasm, and constrained global uranium supply. If UEC provides production guidance updates showing accelerating output, the stock could rally regardless of the loss. Watch uranium spot (Sprott Physical Uranium Trust, SRUUF) as the leading indicator — UEC will follow spot, not beat it.


FDS — FactSet Research Systems Inc. | Reports: Wednesday, September 30 (Before Open) Consensus: EPS $4.32 | Revenue $0.63B Action: HOLD — Steady compounder but rich valuation limits upside; a beat is likely already priced in. Claude’s take: FactSet is a financial data and analytics provider serving buy-side and sell-side institutions. It’s essentially a high-quality SaaS business in financial services — sticky recurring revenue, high retention, but slow growth in an environment where Bloomberg and Refinitiv remain dominant and AI-native data providers are entering the market. The $4.32 EPS on $0.63B revenue is a modest but achievable bar. FactSet typically delivers consistent, low-drama beats. The issue for swing traders: this stock is a slow mover. Unless FDS dramatically raises or cuts guidance, the post-earnings move will be in the 2-4% range — not enough to justify the options premium. Better as a long-term hold than a swing trade event.


PRGS — Progress Software Corp. | Reports: Wednesday, September 30 (After Close) Consensus: EPS $1.16 | Revenue $0.25B Action: HOLD/WATCH — Mid-size software company with M&A integration risk; modest expectations. Claude’s take: Progress Software makes developer tools, data connectivity products, and application development platforms. It’s a steady but unexciting mid-cap software name that has grown largely through acquisition (Telerik, Ipswitch, Chef, MarkLogic). The $1.16 EPS on $0.25B revenue is a manageable bar. The key swing trade question: is Progress Software’s ARR growth re-accelerating, or is it facing churn as customers consolidate vendors? Post-AI-transformation, many enterprises are rationalizing their middleware and connectivity tool vendors. If Progress shows strong ARR and NRR (net revenue retention), the stock could grind higher. If ARR decelerates, expect a gap down into the mid-single digits percentage range.


ATCH — AtlasClear Holdings, Inc. | Reports: Wednesday, September 30 (After Close) Consensus: EPS -$0.01 | Revenue $0.01B Action: AVOID — Micro-cap financial services; no meaningful setup. Claude’s take: AtlasClear is a small financial services and clearing company. With negligible revenue and a de minimis EPS estimate, this is not an actionable swing trade. The stock likely trades on news flow and retail speculation rather than fundamentals.


BSET — Bassett Furniture Industries, Inc. | Reports: Wednesday, September 30 (After Close) Consensus: EPS $0.13 | Revenue $0.08B Action: AVOID — Housing-adjacent furniture company in a challenged demand environment; no compelling setup. Claude’s take: Bassett Furniture is a small-cap furniture manufacturer and retailer with tight exposure to US housing turnover activity. With existing home sales at multi-decade lows through 2024-2025 as homeowners with locked-in 3% mortgages refuse to sell, demand for home furnishings has been structurally suppressed. The $0.13 EPS on $0.08B revenue is a tiny number with limited swing trade interest. Skip it.


📅 Thursday, October 1


NKE — NIKE, Inc. | Reports: Thursday, October 1 (After Close) Consensus: EPS $0.44 | Revenue $11.43B Action: BUY (tactical, into weakness) — The most anticipated name of the second half of the week; a turnaround story with sentiment at a low ebb. Claude’s take: Nike is the second most-anticipated report of the week (score: 24) and arguably the most emotionally charged name on the calendar — it’s a former mega-cap darling that has been in a prolonged restructuring. The $0.44 EPS on $11.43B revenue reflects dramatically reduced expectations after several consecutive quarters of inventory destocking, channel partner friction, and market share losses to On Running (ONON), Hoka (DECK), and New Balance in key footwear categories. CEO Elliott Hill, who returned in late 2024, has been executing a multi-quarter brand reinvestment strategy: pulling back from DTC, re-engaging wholesale partners, and rebuilding the product pipeline. The setup here is interesting for swing traders precisely because sentiment is so negative — NKE may be in “easy beat” territory if the restructuring is progressing faster than the Street models. Watch for: (1) North America wholesale revenue trajectory, (2) gross margin recovery (key structural indicator), (3) China commentary (any green shoots in the Greater China segment would be a significant upside surprise). If NKE reports $0.44+ EPS with stable or improving GM% and any positive China commentary, expect a 5-8% gap up. The risk: if the Street decides this is another quarter of “restructuring progress” with no revenue acceleration, the stock will fade. I’d buy the stock on any weakness in the two days before earnings if it pulls to the 50-day moving average — the risk/reward is asymmetrically positive given how low the bar is.


ACN — Accenture plc | Reports: Thursday, October 1 (Before Open) Consensus: EPS $3.19 | Revenue $18.01B Action: BUY — Best-in-class IT services compounder with AI consulting tailwinds; another clean beat setup. Claude’s take: Accenture is the global leader in IT consulting and digital transformation services, and it’s one of the best “AI monetization proof” stocks in the market — not because it builds AI models, but because it helps the Fortune 500 actually implement them, which is where the real money is in enterprise AI spending. The $3.19 EPS on $18.01B revenue is a high bar in absolute terms, but Accenture has consistently beat and raised for years. The key metric is “bookings” — new contract wins, which is the leading indicator for future revenue. If bookings come in above $20B for the quarter (versus the ~$18-19B range), that signals accelerating AI services demand and would be a meaningful positive catalyst. Accenture typically moves 5-8% on earnings. Given the stock has historically commanded a premium multiple justified by execution consistency, I’d be a buyer into any pre-earnings dip and would hold through the print. This is the cleanest large-cap earnings trade of the week after MU.


AYI — Acuity Inc. | Reports: Thursday, October 1 (Before Open) Consensus: EPS $5.32 | Revenue $1.26B Action: HOLD/WATCH — Lighting and intelligent spaces company; real estate/construction exposure creates uncertainty. Claude’s take: Acuity (formerly Acuity Brands) is a manufacturer of lighting systems and building intelligence solutions — smart sensors, controls, and connected building platforms. The $5.32 EPS on $1.26B revenue is a reasonable bar for a company that has demonstrated consistent operational improvement. The risk is macro-driven: commercial construction activity has been sluggish as higher interest rates suppressed new building starts through 2024-2025. If rates have come down enough to re-stimulate construction project pipelines, Acuity could surprise to the upside on its intelligent spaces segment. Watch for data center-related lighting/infrastructure wins, which would be a secular positive. Not the most exciting swing trade, but a steady name in a cyclical recovery — worth owning in a diversified industrials position if the setup looks clean technically.


MKC — McCormick & Company, Incorporated | Reports: Thursday, October 1 (Before Open) Consensus: EPS $0.75 | Revenue $1.98B Action: HOLD/AVOID — Spice and flavor company; staples multiple compression ongoing, GLP-1 headwinds a long-term concern. Claude’s take: McCormick is the world’s largest spice and flavoring company — a classic consumer staples “safe haven” name that has been anything but safe over the past two years as the sector de-rated on higher-for-longer rates (long-duration bonds competing with dividend stocks) and GLP-1 drug adoption reducing consumer food consumption broadly. The $0.75 EPS on $1.98B consensus is a steady, predictable number for a steady, predictable business. The swing trade thesis is limited: McCormick rarely delivers dramatic beats or misses, and the stock moves 2-4% on earnings at most. Unless there’s a significant gross margin beat driven by lower input costs (pepper, garlic, logistics), I wouldn’t build a swing trade around this print. The better trade is to observe how the stock reacts as a sentiment indicator for the broader consumer staples sector heading into the holidays.


NB — NioCorp Developments Ltd. | Reports: Thursday, October 1 (Before Open) Consensus: EPS -$0.03 | Revenue $0 Action: AVOID — Pre-revenue critical minerals development company; binary permitting/financing risk. Claude’s take: NioCorp is developing the Elk Creek Critical Minerals Project in Nebraska, targeting niobium, scandium, and titanium production. With zero revenue and a -$0.03 EPS estimate, this is purely a project development update. The critical minerals thesis is strategically sound (niobium demand from EV batteries and high-strength steel), but NioCorp faces the same challenges as all development-stage miners: financing risk, permitting timelines, and commodity price volatility. No swing trade setup here without a major catalyst announcement.


CAST — FreeCast, Inc. | Reports: Thursday, October 1 (After Close) Consensus: EPS -$0.08 | Revenue ~$0 Action: AVOID — Micro-cap streaming technology company; no meaningful financial setup. Claude’s take: FreeCast operates a streaming search and discovery platform. With -$0.08 EPS and minimal revenue, this is a speculative micro-cap story with no swing trade merit. The streaming aggregation space is brutally competitive and dominated by Apple TV, Roku, and Amazon’s Fire platform.


TBN — Tamboran Resources Corporation | Reports: Thursday, October 1 (After Close) Consensus: EPS -$0.25 | Revenue $0 Action: AVOID — Pre-revenue Australian shale gas developer; no near-term earnings catalyst. Claude’s take: Tamboran is developing natural gas resources in Australia’s Beetaloo Basin. Zero revenue, consistent losses, long development timeline. The story is interesting from a global LNG supply perspective, but this is a multi-year development thesis, not a swing trade.


EPOL — iShares MSCI Poland ETF | Reports: Thursday, October 1 (Before Open) Consensus: N/A | Revenue N/A Action: WATCH — ETF distributions are not earnings events; flag this only if you have EM Europe exposure. Claude’s take: EPOL is an ETF, not an operating company — its “earnings” are dividend distributions. This is irrelevant to the earnings calendar in any meaningful sense. If you hold European emerging market exposure, note that Poland remains one of the stronger EM European economies with strong NATO alignment and EU fund inflows, but this is not an actionable earnings event.


📅 Friday, October 2


NG — NovaGold Resources Inc. | Reports: Friday, October 2 (Before Open) Consensus: EPS -$0.08 | Revenue $0 Action: AVOID — Pre-revenue gold developer; earnings report is not the catalyst to trade. Claude’s take: NovaGold is developing the massive Donlin Gold project in Alaska alongside Barrick Gold. With zero revenue and a steady loss rate, this is entirely a gold price/project development story. The relevant data point is gold spot price (consistently elevated in 2025-2026 above $3,000/oz in the AI/geopolitical safe haven environment), but NovaGold won’t generate revenue until Donlin reaches production — which is years away. Not a swing trade setup.


AFB, AMTY, BABB, BUFF, CJREF, HTLM, MCBK — Various Micro/Nano-caps | Reports: Friday, October 2 (Before Open) Action: AVOID ALL — No estimates, minimal liquidity, no actionable setups. Claude’s take: Alliance National Municipal Income Fund (AFB) is a closed-end fund — not an operating company earnings event. Amerityre (AMTY) is a specialty tire micro-cap. BAB Inc. (BABB) operates Big Apple Bagels franchises. Blue Buffalo (BUFF) is a pet food brand that was acquired by General Mills years ago — this ticker appearing is likely a data artifact. Corus Entertainment (CJREF) is a Canadian media company. HomesToLife (HTLM) is a Singapore furniture retailer. Madison County Financial (MCBK) is a tiny community bank. None of these represent actionable swing trade opportunities.


Economic Calendar

⚠️ Timing Note: All three economic events in the provided data are dated September 24–25, 2026, which fall in the prior week (the week ending September 25). These events occurred before the September 28 trading week begins. However, their outcomes will directly influence the opening tone of the September 28 week and are worth reviewing for carry-over impact.


Unemployment Claims — Thursday, September 25 | 8:30 AM ET (Prior Week) Forecast: 201K | Previous: 196K Market impact: The modest expected uptick from 196K to 201K is still well within the range consistent with a healthy labor market — readings below 220K generally signal no imminent deterioration in employment. If claims came in below 196K (a beat), that would reinforce the “soft landing” narrative and support risk assets broadly heading into the September 28 week. If claims surprised higher (above 215K), that would increase recession anxiety and weigh on cyclicals (consumer discretionary, industrials, financials) at Monday’s open. The carry-over impact on this week’s earnings is most relevant for CCL, KMX, and NKE — all consumer-facing companies that are directly sensitive to labor market health. A strong claims print is a green light for those positions.


Revised UoM Consumer Sentiment — Friday, September 25 | 10:00 AM ET (Prior Week) Forecast: 47.5 | Previous: 47.8 Market impact: A Consumer Sentiment reading of 47.5 is historically very low — the long-run average is around 86. This reflects the sustained consumer anxiety about inflation, interest rates, and economic uncertainty that has characterized the post-2022 environment. A reading at or below 47.5 carries directly into this week’s consumer-facing earnings (CCL, KMX, NKE, MKC, CAG) as a headwind narrative. If the revised number came in higher than 47.8 (a positive surprise), that would be the more interesting setup — it would suggest the preliminary read was too pessimistic, and consumer discretionary stocks could catch a bid at Monday’s open. A downside miss (below 47) would further pressure consumer-facing names and give short sellers ammunition heading into CCL and KMX earnings on Tuesday.


Revised UoM Inflation Expectations — Friday, September 25 | 10:00 AM ET (Prior Week) Forecast: N/A | Previous: 4.6% Market impact: Long-run inflation expectations at 4.6% remain significantly above the Fed’s 2% target, which means the Federal Reserve cannot declare mission accomplished and pivot to aggressive easing. Elevated inflation expectations are a structural negative for rate-sensitive sectors (real estate, utilities, long-duration growth stocks) and a headwind for consumer confidence (explaining the 47.5 sentiment reading above). If the revised reading came in materially below 4.6% (say, 4.2% or lower), that would be a meaningful positive surprise — it would signal that household inflation psychology is finally breaking, which would support the bond market and risk assets. Watch the 10-year Treasury yield at Monday’s open for confirmation of where the inflation expectations read landed.


IPO Watch

The IPO list provided reflects offerings priced in May 2026, approximately 4–5 months before this trading week. These are no longer “new” IPOs — they are post-IPO seasoned positions at this point. Most will have passed their initial 25-day quiet period and many may be approaching or past their 180-day lock-up expiry window (which would fall around November 2026 for May IPOs). Here are the most notable names:


CBRS — Cerebras Systems Inc. | $5.55 Billion offering (NASDAQ Global Select, $185.00) Claude’s take: Cerebras is the most significant IPO on this list by a wide margin — a $5.55B offering for an AI chip company that has positioned itself as a direct challenger to Nvidia’s GPU monopoly in AI inference workloads. Their wafer-scale engine (WSE) architecture enables dramatically faster inference than GPU clusters for certain model architectures. At $185/share, the IPO valuation was aggressive — this is a pre-profitability, hypergrowth AI hardware story. Four to five months post-IPO, the critical question is whether CBRS has traded above or below its IPO price. Given how volatile AI chip names have been, retail should NOT chase this on day 1 of a new trading week unless there’s a clear technical setup. The lock-up expiry in November 2026 is the more important event for swing traders — insider selling pressure at lock-up expiry often creates the best entry point for a high-quality name at a 10-20% discount. If MU’s earnings this week are strong, CBRS could see sympathy buying as a sector comrade.


BXDC — Blackstone Digital Infrastructure Trust Inc. | $1.75 Billion offering (NYSE, $20.00) Claude’s take: Blackstone Digital Infrastructure is a data center and digital infrastructure REIT/trust — a direct play on hyperscaler AI buildout demand. At $1.75B, this was a substantial and notable offering. The AI data center buildout theme is one of the strongest secular trends in real estate and infrastructure, and Blackstone’s pedigree as an operator adds institutional credibility. If this trust has a stable distribution yield (typical for infrastructure vehicles), it may have attracted income investors and exhibited lower volatility than pure-play AI growth names. As a swing trade candidate this week: watch whether CBRS (Cerebras) and MU earnings catalyze sympathy buying in AI infrastructure plays. BXDC would likely be a beneficiary of positive MU earnings sentiment. The risk: if interest rates moved higher in Q3 2026, REIT-structure income vehicles face multiple compression regardless of fundamentals.


FRVO — Fervo Energy Co | $1.89 Billion offering (NASDAQ Global Select, $27.00) Claude’s take: Fervo Energy is a geothermal energy company that raised nearly $1.9B at IPO — a landmark transaction for the enhanced geothermal systems (EGS) space. The AI data center power demand narrative is directly bullish for Fervo, as hyperscalers (Google has a partnership with Fervo) are desperate for carbon-free, 24/7 baseload power that solar and wind cannot provide. This is arguably the most strategically interesting non-AI-chip name on the IPO list. For swing traders this week: any positive commentary from Accenture (ACN) about data center energy infrastructure demand would be read-through bullish for FRVO. The risk is that EGS projects have long development timelines and high upfront capital costs — revenue will not ramp quickly. This is a 12-24 month swing trade thesis, not a weekly setup, but it’s worth putting on a watchlist.


LCLN — Lincoln International, Inc. | $421 Million offering (NYSE, $20.00) Claude’s take: Lincoln International is a leading mid-market investment bank and M&A advisory firm that went public in May 2026. This is directly relevant to the JEF (Jefferies) earnings read-through this week — if Jefferies reports strong M&A and advisory revenue on Monday, Lincoln International should benefit from the same underlying deal activity. The mid-market M&A segment (transactions below $1B) tends to be more resilient than mega-cap M&A in volatile markets. Lincoln’s IPO at $20.00 was reasonably priced for the sector. If the stock has held above or near $20, this could be a solid swing trade long on the back of JEF’s earnings. Watch JEF’s print first, then buy LCLN on any post-JEF sector momentum.


SPCX — Space Exploration Technologies Corp (SpaceX) | ~$75 Billion filing (NASDAQ, filed 5/20/2026) Claude’s take: The SpaceX IPO filing is the most headline-grabbing item in the entire IPO section — a potential $75B offering would be one of the largest in US market history, dwarfing Facebook’s $16B IPO in 2012 and Alibaba’s $25B in 2014. However, this is still a filed IPO as of May 2026, not a priced one, meaning it was in the SEC registration process. Whether it has priced and begun trading by September 28, 2026 is unknown from the data provided — but if SpaceX begins trading in or around this week, it would be the defining market event of the year, potentially attracting hundreds of billions in retail and institutional flows and creating sympathy momentum across the entire space/defense/satellite sector (ASTS, RKLB, PLTR, etc.). Retail should NOT buy a SpaceX IPO on day 1 at any premium — wait for the first 30-day consolidation. The lock-up expiry will be the real opportunity.


QNT — Quantinuum Inc. | $1.68 Billion filing (filed 5/08/2026) Claude’s take: Quantinuum is a leading quantum computing company (formed from the merger of Honeywell Quantum Solutions and Cambridge Quantum). A $1.68B IPO filing puts this in the major-event category for the quantum computing sector, which has attracted massive attention from Microsoft (Majorana), Google (Willow chip), and IBM. If Quantinuum has priced and is trading by this week, it would be a significant reference point for the quantum computing investment thesis. Swing traders should approach this like any other deep-technology pre-revenue IPO: wait for the dust to settle, let the institutional book-building premium fade, and look for an entry 10-15% below the IPO price. The long-term thesis is compelling; the short-term risk is high.


Week Ahead Summary

  • 🎯 Biggest Opportunity — Micron (MU) Wednesday After Close: This is the most important earnings event of the week by a factor of five (anticipation score 127). A beat-and-raise on HBM revenue and AI data center demand could trigger a 5-10% gap up in MU and ignite a broader semiconductor rally heading into October’s big-tech earnings season (Alphabet, Meta, Microsoft, Amazon all report in late October). Position ahead of the print with defined risk — buy a call spread rather than stock to manage the elevated implied volatility. If MU disappoints, the entire QQQ complex will feel it.

  • ⚠️ Biggest Risk — Consumer Confidence Deterioration Feeding Into Tuesday’s Prints: The UoM Consumer Sentiment reading of 47.5 (prior week) represents historically depressed consumer confidence. If this bleeds into CCL and KMX earnings on Tuesday morning and either company shows deteriorating forward bookings or unit economics, we could see a broader selloff in consumer discretionary names that spills into the NKE print on Thursday. Watch CCL’s booking commentary like a hawk — it’s the best real-time read on consumer willingness to spend on big-ticket leisure items.

  • 📊 Key Levels to Watch — SPY and QQQ: Heading into this week, SPY’s key support is the 200-day moving average and the prior consolidation zone — any break below on high volume would shift the posture to defensive. QQQ’s behavior is entirely dictated by MU’s Wednesday print; a strong MU number could push QQQ to test the upper end of its recent range, while a miss could trigger a retest of the September lows. Watch the VIX: if it spikes above 25 into the MU print, the options market is pricing in serious tail risk.

  • 🔗 Sector Chain Reaction to Watch: JEF (Monday AC) → LCLN and XLF reaction Tuesday. CCL (Tuesday BO) → consumer discretionary sector tone for the week. MU (Wednesday AC) → semiconductors (NVDA, AMD, AMAT) and AI infrastructure broadly. ACN (Thursday BO) → IT services, cloud, and digital transformation names. NKE (Thursday AC) → consumer brands and athletic apparel (LULU, ONON, DECK). Each print is a domino — the week has a clear narrative arc from financials → consumer → semis → tech services → consumer brands.

  • 🧭 Overall Positioning — Balanced with a Semiconductor Tilt: The macro backdrop (suppressed consumer sentiment, still-elevated inflation expectations) argues for selectivity rather than broad risk-on positioning. However, the AI infrastructure cycle is genuinely accelerating, and MU/ACN/JBL represent three distinct ways to be long that theme with different risk profiles. My recommended posture: overweight semis/AI infrastructure, neutral consumer discretionary (wait for CCL/NKE results before adding), underweight consumer staples (CAG, MKC) and BPO/legacy services (CNXC). Reduce exposure into MU’s print if the position is already large — the binary risk is real, even for bulls. After MU reports, let the market’s reaction guide you for the rest of October.